One synthetic mRNA workflow
The working public demonstration covers one bounded HEK293T research-use fixture and a fixed result schema.
Company SingularCell
Our mission is to make it possible to send a biotech study between organizations without losing the decision, assumptions, evidence or accountability that make the result useful.
The working public demonstration covers one bounded HEK293T research-use fixture and a fixed result schema.
A qualified adviser and laboratory partner will review one narrow context before any controlled pilot.
Reusable contracts, declarations and evidence records can become an operating layer across study partners.
Software tests do not establish scientific validity, laboratory equivalence, clinical suitability or customer demand. SingularCell keeps those claims gated until the corresponding human, scientific and commercial evidence exists.